Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

被引：0
|
作者：
Andrea Camerini
Cheti Puccetti
Sara Donati
Chiara Valsuani
Maria Cristina Petrella
Gianna Tartarelli
Paolo Puccinelli
Domenico Amoroso
机构：
[1] Versilia Hospital and Istituto Toscano Tumori,Medical Oncology
来源：
BMC Cancer | / 15卷
关键词：
Elderly; Non-small-cell lung cancer; Metronomic vinorelbine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer
    Choong, Nicholas W.
    Mazcer, Ann M.
    Hoffman, Philip C.
    Rudin, Charles M.
    Winegarden, Jerome D., III
    Villano, J. Lee
    Kozloff, Mark
    Wade, James L., III
    Sciortino, David F.
    Szeto, Livia
    Vokes, Everett E.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (03) : 245 - 251
  • [32] Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients
    Veronesi, A
    Crivellari, D
    Magri, MD
    Cartei, G
    Mansutti, M
    Foladore, S
    Monfardini, S
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (10) : 1809 - 1811
  • [33] Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer
    Masters, GA
    Hahn, EA
    Shevrin, DH
    Kies, MS
    LUNG CANCER, 2003, 39 (02) : 221 - 226
  • [34] Phase II trial of single-agent oral vinorelbine in elderly (≥70 years) patients with advanced non-small-cell lung cancer and poor performance status
    Camerini, A.
    Valsuani, C.
    Mazzoni, F.
    Siclari, O.
    Puccetti, C.
    Donati, S.
    Rondini, M.
    Tartarelli, G.
    Puccinelli, P.
    Di Costanzo, F.
    Amoroso, D.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1290 - 1295
  • [35] A Phase Ⅱ Trial of Gefitinib as Maintenance Therapy after First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer in China
    Lu Yang 1
    1Department of Thoracic Medical Oncology
    ChineseJournalofCancerResearch, 2010, 22 (01) : 1 - 9
  • [36] A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer
    Mori, Kiyoshi
    Kobayashi, Hiroyuki
    Kamiyama, Yukari
    Kano, Yasuhiko
    Kodama, Tetsuro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 73 - 78
  • [37] A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer
    Kiyoshi Mori
    Hiroyuki Kobayashi
    Yukari Kamiyama
    Yasuhiko Kano
    Tetsuro Kodama
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 73 - 78
  • [38] Efficacy and feasibility of gemcitabine and carboplatin as first-line chemotherapy in elderly patients with advanced non-small cell lung cancer
    Lim, Kyu-Hyoung
    Lee, Hui-Young
    Song, Seo-Young
    CHINESE MEDICAL JOURNAL, 2013, 126 (24) : 4644 - 4648
  • [39] A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)
    Giorgio, CG
    Pappalardo, A
    Russo, A
    Giuffrida, D
    Santini, D
    Petralia, G
    Castorina, S
    Nunzio, R
    Failla, G
    Bordonaro, R
    LUNG CANCER, 2006, 51 (03) : 357 - 362
  • [40] Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial
    Rossi, David
    Dennetta, Donatella
    Ugolini, Marcello
    Catalano, Vincenzo
    Alessandroni, Paolo
    Giordani, Paolo
    Baldelli, Anna Maria
    Casadei, Virginia
    Graziano, Francesco
    Fedeli, S. Luzi
    TARGETED ONCOLOGY, 2010, 5 (04) : 231 - 235
12345